CD19 and systemic sclerosis: In addition to these patients, Merkt et al. [36] described the compassionate use of a CD19 CAR-T in a 38-year-old patient with Scl-70+ systemic sclerosis with pulmonary involvement by progressive non-specific interstitial pneumonia (NSIP).